Health care players are crossing traditional boundaries — and health care providers expect recent combinations to overturn the industry. In light of recent mergers such as CVS-Aetna and Optum-DaVita, we conducted an NEJM Catalyst Buzz Survey, sponsored by BDO, to ask the NEJM Catalyst Insights Council what impact they expect from innovative mergers and potential new entrants. By a large majority, members of the Insights Council, a qualified group of U.S. executives, clinical leaders, and clinicians involved in health care delivery, expect these mergers to disrupt the prevailing order over the next 3 years. They expect the greatest impact from the CVS-Aetna deal (if approved), followed by Amazon entering the fray. (This survey was conducted just before Amazon, JPMorgan Chase, and Berkshire Hathaway said they would form an independent health care company, which sent shock waves throughout health care and the stock market.) Google and Apple are also expected to have a significant disruptive influence, though neither company has specified its plans for the health care industry.
Insights Report by Jon Bees
NEJM Catalyst Insights Council members say that while transparency might be necessary, we have to change the way care is delivered.
Insights Report by Leemore Dafny & Chris DeRienzo
Efforts to mitigate rising health care costs have left most industry participants — patients, providers, and payers alike — frustrated at the lack of progress. While there is plenty of blame to go around, a significant open question remains: how responsible are patients for reducing costs?
Article by John P. Andrawis, Mark McClellan & Kevin J. Bozic
Dell Medical School at The University of Texas at Austin has improved outcomes and reduced costs for musculoskeletal care with a multidisciplinary Musculoskeletal Institute and bundled payment model.
Article by David Lansky & Jeff Micklos
Care management should be payer-agnostic at its core.
Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program
Article by JP Sharp, Patrick H. Conway & Rahul Rajkumar
We believe North Carolina can be a model for the nation.
Article by Nicholas Bagley, Amitabh Chandra, Craig Garthwaite & Ariel D. Stern
Three proposals for improving the law to reflect 21st-century drug development practices.
Article by Dana P. Goldman, Karen Van Nuys, Wei-Han Cheng, Jakub P. Hlávka, Luca Pani, Sylvain Chassang & Erik Snowberg
Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.
Insights Report by NEJM Catalyst & University of Utah Health
An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.
Case Study by John Grady-Benson, Michael Cremins, Elizabeth Olson, Nishwant Swami & Steven Schutzer
The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.
Case Study by Patrick Cronin, Shailesh Dominic Aranha & Alexa Boer Kimball
Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.